Enabling the Ideal Research Environment: P43339 pLV3-CMV-OVAL(Ck)-CopGFP-Puro Supports the Study of VCP-Mediated Regulation of CD8+ T Cells in HCC

Original Article:https://doi.org/10.1038/s41392-024-02120-8

Journal: Signal Transduction and Targeted Therapy
Publication Date: January 2025
Impact Factor: 40.8
DOI: 10.1038/s41392-024-02120-8

Original Article Title:
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+ T cells function in the HCC microenvironment

Chinese Title:
VCP下游代谢产物甘油-3-磷酸（G3P）抑制CD8+T细胞在HCC微环境中的功能

原文链接：https://doi.org/10.1038/s41392-024-02120-8

Summary of the Study

The tumor microenvironment (TME) of hepatocellular carcinoma (HCC) is often characterized by impaired immune cell function, including dysfunction of CD8+ T cells, which play a central role in antitumor immunity.

In this study, the researchers found that valosin-containing protein (VCP) suppresses the activation, expansion, and cytotoxic function of CD8+ T cells, thereby weakening their ability to eliminate HCC cells.

Because sustained antigen stimulation is important for CD8+ T-cell activation, ovalbumin (OVA) is widely used as a model antigen in biomedical research. To establish a controlled in vitro model that mimics aspects of antigen-driven tumor–T-cell interactions, the researchers generated a stable OVA-overexpressing Hepa 1–6 cell line (Hepa 1–6-OVA) and co-cultured these cells with CD8+ T cells.

Stable OVA expression in tumor cells provided a defined antigenic system for investigating the interaction between tumor cells and CD8+ T cells.

Key Findings

When VCP expression was knocked down in Hepa 1–6-OVA cells, co-culture with CD8+ T cells resulted in:

• Reduced CD8+ T-cell apoptosis
• Increased apoptosis of Hepa 1–6-OVA tumor cells
• Enhanced CD8+ T-cell proliferation
• Increased expression of cytokines and effector molecules, including GzmB and IFN-γ

These effects were observed in both direct-contact and non-contact co-culture systems.

The researchers further used a Transwell co-culture system to determine whether VCP influenced CD8+ T-cell function through soluble factors rather than direct cell–cell contact. VCP depletion in tumor cells still increased tumor-cell apoptosis, reduced CD8+ T-cell apoptosis, and promoted CD8+ T-cell proliferation and cytokine expression.

These findings support the conclusion that VCP can suppress CD8+ T-cell function and expansion through downstream metabolic mechanisms.

Construction of the Hepa 1–6-OVA Stable Cell Line

To generate a stable tumor-cell model with sustained OVA expression, the research team selected P0268 (pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro) after communicating with the MiaoLingPlasmid team.

Based on this vector, the target construct P43339 (pLV3-CMV-OVAL(chicken)-CopGFP-Puro) was generated.

The lentiviral vector system was then used to establish an OVA-overexpressing Hepa 1–6 stable cell line, providing a suitable cellular model for subsequent CD8+ T-cell functional studies.

Key Experimental Evidence

The article explicitly identifies the plasmids used in the study in the Materials and Methods section under “Plasmids”:

1.png

The plasmids pCMV-His-UB (P4836) and pLV3-CMV-OVAL(chicken)-CopGFP-Puro (P43339) used in the study were both obtained from MiaoLingBio.

In the section investigating the effects of VCP on CD8+ T-cell function, the researchers specifically described co-culture experiments involving CD8+ T cells and OVA-expressing Hepa 1–6 cells (Hepa 1–6-OVA):

2.png

The results showed that Vcp depletion in tumor cells enhanced CD8+ T-cell cytotoxicity, increased tumor-cell apoptosis, reduced CD8+ T-cell apoptosis, and increased the levels of GzmB and IFN-γ, consistent with the in vivo observations.

The researchers also used a Transwell-based non-contact co-culture system to determine whether VCP affected antigen presentation. Vcp depletion in tumor cells continued to increase tumor-cell apoptosis, reduce CD8+ T-cell apoptosis, and promote CD8+ T-cell proliferation and cytokine expression, suggesting that the observed effects were not simply attributable to altered tumor antigen presentation.

3.png

The Key Role of P0268 in the Experimental System

1. Broad Applicability and Efficient Gene Expression

P0268 (pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro) is a versatile mammalian lentiviral expression vector designed for efficient expression of heterologous genes in a broad range of mammalian cell types.

Its expression and selection features make it suitable for generating stable cell populations for downstream functional studies.

In this study, the vector provided the foundation for constructing the OVA-overexpressing lentiviral plasmid P43339, which was subsequently used to establish the Hepa 1–6-OVA cell model.

2. Improved Experimental Efficiency

P0268 contains CopGFP, providing a convenient fluorescent reporter for monitoring transduction and expression.

Fluorescence can serve as a rapid indicator of successful lentiviral delivery and enrichment, reducing the need to rely exclusively on molecular assays for initial screening.

This feature can help researchers monitor cell populations efficiently during stable cell-line development.

3. Efficient Lentiviral Production and Stable Cell-Line Generation

The lentiviral vector architecture of P0268 allows the construct to be incorporated into a lentiviral delivery system suitable for stable gene expression in target cells.

In this study, the vector backbone supported the construction of P43339 pLV3-CMV-OVAL(chicken)-CopGFP-Puro, enabling the generation of a stable OVA-expressing Hepa 1–6 cell model.

The resulting Hepa 1–6-OVA cells provided a defined experimental system for studying tumor–immune cell interactions and investigating how VCP and its downstream metabolic pathways influence CD8+ T-cell function.

Why an OVA-Expressing Tumor Cell Model Matters

OVA is widely used as a model antigen in immunology research because it provides a defined antigenic system for studying antigen-specific immune responses.

In this study, stable OVA expression in Hepa 1–6 cells established a reproducible tumor-cell model that could be used to investigate CD8+ T-cell responses under controlled experimental conditions.

By combining:

OVA-expressing tumor cells → CD8+ T-cell co-culture → VCP manipulation → functional and molecular analyses

the researchers were able to investigate the relationship between tumor-cell metabolism and immune-cell function.

MiaoLingBio Supports Your Research Workflow

From plasmid backbone selection and construct design to stable cell-line development, the appropriate plasmid system can provide an important foundation for complex cellular and molecular biology studies.

In this study, P0268 served as the vector backbone for constructing P43339, ultimately supporting the generation of Hepa 1–6-OVA cells used to investigate VCP-mediated regulation of CD8+ T-cell function in the HCC tumor microenvironment.

For researchers studying tumor immunology, T-cell function, cancer metabolism, stable cell lines, or tumor–immune interactions, suitable lentiviral expression vectors can help establish reproducible experimental models and accelerate downstream research.

P43339 pLV3-CMV-OVAL(chicken)-CopGFP-Puro — a MiaoLingBio plasmid used in published HCC immunology research.